Dianthus Therapeutics, Inc. (DNTH)

NASDAQ: DNTH · Real-Time Price · USD

17.86

+0.18 (1.02%)

At close: May 29, 2025, 4:00 PM

18.00

+0.14 (0.78%)

After-hours: May 29, 2025, 7:24 PM EDT

Dianthus Therapeutics Employees

Dianthus Therapeutics had 78 employees as of December 31, 2024. The number of employees increased by 25 or 47.17% compared to the previous year.

Employees

78

Change (1Y)

25

Growth (1Y)

47.17%

Revenue / Employee

$83,641

Profits / Employee

-$1,291,436

Market Cap

574.38M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	78	25	47.17%
Dec 31, 2023	53	21	65.63%
Dec 31, 2022	32	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000
AbbVie	55,000

Employee Rankings

DNTH News

18 hours ago - Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference - GlobeNewsWire
7 days ago - Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors - GlobeNewsWire
17 days ago - Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results - GlobeNewsWire
24 days ago - Dianthus Therapeutics Completes Enrollment of Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis With Top-Line Results Expected in September - GlobeNewsWire
4 weeks ago - Dianthus Therapeutics to Participate in Two Upcoming Investor Events - GlobeNewsWire
2 months ago - Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results - GlobeNewsWire
3 months ago - Dianthus Therapeutics Strengthens Strategic Commercial Leadership With Appointment of John C. King as Chief Commercial Officer and Welcomes Sujay Kango, A Seasoned Commercial Leader, to Board of Directors - GlobeNewsWire
3 months ago - Dianthus Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewsWire